| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2639779 | American Journal of Infection Control | 2006 | 4 Pages |
Abstract
We conclude that the change from Tubersol to Aplisol resulted in falsely elevated conversion rates. Our results support the guidelines from the Centers for Disease Control and Prevention recommendations that 1 product should be used consistently in populations undergoing periodic testing.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Kari A. MD, MPH, Sandra C. RN, BSN, CIC, Kim RN, BSN, George K. MD, MPH,